Proteolytic cleavage of CD44 is a key regulatory mechanism for the CD44-dependent signaling pathways (19, 20), leading to the release of CD44 ICD, which then is translocated into the nucleus to upregulate cancer stemness-related genes such as Oct4 (24, 25, 26). This evidence concerns the gene CD44 and cancer.